991 related articles for article (PubMed ID: 16854482)
41. Comparison of different definitions of the metabolic syndrome.
Sandhofer A; Iglseder B; Paulweber B; Ebenbichler CF; Patsch JR
Eur J Clin Invest; 2007 Feb; 37(2):109-16. PubMed ID: 17217376
[TBL] [Abstract][Full Text] [Related]
42. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
[TBL] [Abstract][Full Text] [Related]
43. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
[TBL] [Abstract][Full Text] [Related]
44. Metabolic syndrome according to different definitions in a rapidly developing country of the African region.
Kelliny C; William J; Riesen W; Paccaud F; Bovet P
Cardiovasc Diabetol; 2008 Sep; 7():27. PubMed ID: 18801172
[TBL] [Abstract][Full Text] [Related]
45. The metabolic syndrome in Australia: prevalence using four definitions.
Cameron AJ; Magliano DJ; Zimmet PZ; Welborn T; Shaw JE
Diabetes Res Clin Pract; 2007 Sep; 77(3):471-8. PubMed ID: 17350710
[TBL] [Abstract][Full Text] [Related]
46. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
[TBL] [Abstract][Full Text] [Related]
47. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
49. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
50. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences.
Skilton MR; Moulin P; Sérusclat A; Nony P; Bonnet F
Atherosclerosis; 2007 Feb; 190(2):416-22. PubMed ID: 16616756
[TBL] [Abstract][Full Text] [Related]
51. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
[TBL] [Abstract][Full Text] [Related]
52. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of chronic kidney disease in adults with metabolic syndrome.
Emem-Chioma PC; Siminialayi IM; Wokoma FS
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):949-54. PubMed ID: 21912024
[TBL] [Abstract][Full Text] [Related]
54. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
55. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
[TBL] [Abstract][Full Text] [Related]
56. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
[TBL] [Abstract][Full Text] [Related]
58. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women.
Carlsson AC; Wändell PE; Halldin M; de Faire U; Hellénius ML
Metab Syndr Relat Disord; 2009 Jun; 7(3):231-41. PubMed ID: 19284315
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
Zabetian A; Hadaegh F; Azizi F
Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
[TBL] [Abstract][Full Text] [Related]
60. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
